Continuous manufacturing builds on hype but adoption remains gradual
Brexit, Covid-19, and a drive for sustainability has bumped the move towards continuous manufacturing, even though large-scale investment drags
By
Brexit, Covid-19, and a drive for sustainability has bumped the move towards continuous manufacturing, even though large-scale investment drags
ByA total of 27 CMOs have agreed to produce Merck’s molnupiravir for 105 countries in Africa, Asia and the Middle…
ByA report on global API supply chain vulnerabilities indicates the outsized importance of and dependency on overseas manufacturers.
ByDespite a slow return to normal, the impact of Covid-19 is still being felt across the CAR-T cell therapy industry.
ByFrom the value of collaboration to the importance of planning ahead, pharma can learn from Covid-19 when it comes to…
ByThe pharma industry needs to target its entire value chain if it wants to make a real dent in reducing…
ByAn analysis of FDA data shows the majority of drugs in short supply in the US are anaesthetics.
ByThe Covid-19 pandemic has highlighted the need for security and traceability at every step of the drug supply chain.
ByThank you for subscribing to Pharmaceutical Technology